Mes données de santé

Informacijska stranica za pacijente liječene u mreži Unicancer ili uključene u klinička ispitivanja mreže Unicancer

O ovoj stranici

Ciljevi

Impact of the histological margin quality at initial surgery (R0 from the outset vs. R0 after revision surgery) on local relapse-free survival;

a. Impact of the histological margin quality at initial treatment (R0 from the outset vs. R0 after revision surgery) on overall survival.

b. Impact of the histological margin quality at initial surgery (R0 vs R1 vs R2 from the first surgical sequence (before any revision)) on overall survival.

c. Impact of the histological margin quality at initial surgery (R0 vs R1 vs R2 from the first surgical sequence (before any revision)) on local relapse-free survival.

d. Impact of the histological margin quality at initial surgery (R0 initial surgery with or without re-excision) on overall survival.

e. Impact of the histological margin quality at initial surgery (R0 initial surgery with or without re-excision) on local relapse-free survival.

f. Determination of initial treatment parameters which are prognostic for local relapse-free survival : histological subtype, size of tumor, grade, site of tumor, radiation area, biopsy before surgery, pre-operative imaging, neoadjuvant treatment before surgery, quality of first surgery, re-excision, surgeon inside or outside network, early metastasis.

g. Determination of initial treatment parameters which are prognostic for overall survival : histological subtype, size of tumor, grade, site of tumor, radiation area, biopsy before surgery, pre-operative imaging, neoadjuvant treatment before surgery, quality of first surgery, re-excision, surgeon inside or outside network, early metastasis. a. Impact of the histological margin quality at initial treatment (R0 from the outset vs. R0 after revision surgery) on overall survival.

b. Impact of the histological margin quality at initial surgery (R0 vs R1 vs R2 from the first surgical sequence (before any revision)) on overall survival.

c. Impact of the histological margin quality at initial surgery (R0 vs R1 vs R2 from the first surgical sequence (before any revision)) on local relapse-free survival.

d. Impact of the histological margin quality at initial surgery (R0 initial surgery with or without re-excision) on overall survival.

e. Impact of the histological margin quality at initial surgery (R0 initial surgery with or without re-excision) on local relapse-free survival.

f. Determination of initial treatment parameters which are prognostic for local relapse-free survival : histological subtype, size of tumor, grade, site of tumor, radiation area, biopsy before surgery, pre-operative imaging, neoadjuvant treatment before surgery, quality of first surgery, re-excision, surgeon inside or outside network, early metastasis.

g. Determination of initial treatment parameters which are prognostic for overall survival : histological subtype, size of tumor, grade, site of tumor, radiation area, biopsy before surgery, pre-operative imaging, neoadjuvant treatment before surgery, quality of first surgery, re-excision, surgeon inside or outside network, early metastasis. a. Impact of the histological margin quality at initial treatment (R0 from the outset vs. R0 after revision surgery) on overall survival.

b. Impact of the histological margin quality at initial surgery (R0 vs R1 vs R2 from the first surgical sequence (before any revision)) on overall survival.

c. Impact of the histological margin quality at initial surgery (R0 vs R1 vs R2 from the first surgical sequence (before any revision)) on local relapse-free survival.

d. Impact of the histological margin quality at initial surgery (R0 initial surgery with or without re-excision) on overall survival.

e. Impact of the histological margin quality at initial surgery (R0 initial surgery with or without re-excision) on local relapse-free survival.

f. Determination of initial treatment parameters which are prognostic for local relapse-free survival : histological subtype, size of tumor, grade, site of tumor, radiation area, biopsy before surgery, pre-operative imaging, neoadjuvant treatment before surgery, quality of first surgery, re-excision, surgeon inside or outside network, early metastasis.

g. Determination of initial treatment parameters which are prognostic for overall survival : histological subtype, size of tumor, grade, site of tumor, radiation area, biopsy before surgery, pre-operative imaging, neoadjuvant treatment before surgery, quality of first surgery, re-excision, surgeon inside or outside network, early metastasis. a. Impact of the histological margin quality at initial treatment (R0 from the outset vs. R0 after revision surgery) on overall survival.

b. Impact of the histological margin quality at initial surgery (R0 vs R1 vs R2 from the first surgical sequence (before any revision)) on overall survival.

c. Impact of the histological margin quality at initial surgery (R0 vs R1 vs R2 from the first surgical sequence (before any revision)) on local relapse-free survival.

d. Impact of the histological margin quality at initial surgery (R0 initial surgery with or without re-excision) on overall survival.

e. Impact of the histological margin quality at initial surgery (R0 initial surgery with or without re-excision) on local relapse-free survival.

f. Determination of initial treatment parameters which are prognostic for local relapse-free survival : histological subtype, size of tumor, grade, site of tumor, radiation area, biopsy before surgery, pre-operative imaging, neoadjuvant treatment before surgery, quality of first surgery, re-excision, surgeon inside or outside network, early metastasis.

g. Determination of initial treatment parameters which are prognostic for overall survival : histological subtype, size of tumor, grade, site of tumor, radiation area, biopsy before surgery, pre-operative imaging, neoadjuvant treatment before surgery, quality of first surgery, re-excision, surgeon inside or outside network, early metastasis.

Voditelj obrade

Institut de Cancérologie de l'Ouest

Kategorije korištenih podataka
Données d’identification (sans donnée nominative) / Données de santé
Origine de données utilisées
Soins
Institut de Cancérologie de l'Ouest (Nantes et Angers)
2010
2011
2012
2013
2014
2015
2016
2017
Populacija koja je predmet istraživanja ili obrade podataka

Cutaneous sarcoma of the base with a representation of more than 20 cases Patient who underwent a surgery of cutaneous sarcoma and whose file was included in the NETSARC database From 01/01/2010 to 30/12/2017

Pravna osnova

 6.e) RGPD le traitement est nécessaire à l'exécution d'une mission d'intérêt public

Interni i vanjski primatelji podataka

Institut de Cancérologie de l'Ouest

Datum početka istraživanja
02/11/2020
Razdoblje čuvanja podataka

Conservation pendant 2 ans après la valorisation (publication/article, these, présentation orale, poster, autre) des résultats de la recherche. Puis archivage avec un accès restreint aux personnes intervenant dans la recherche, pendant une durée limitée de 3 ans (5ans au total post publication)

Kako biste zaštitili svoje zdravstvene podatke, preporučuje se da u ovom obrascu ne otkrivate osobne zdravstvene informacije o sebi ili članu obitelji.
Pozivamo vas da navedete ustanovu u kojoj se liječite i osigurat ćemo uspostavljanje odgovarajuće veze kako bismo zajamčili ostvarivanje vašeg zahtjeva.
CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
Cette question sert à vérifier si vous êtes un visiteur humain ou non afin d'éviter les soumissions de pourriel (spam) automatisées.

Informacije prikupljene u upitniku ne pohranjuju se na ovoj web stranici, već se šalju voditelju obrade podataka navedenom u obrascu za istraživanje. Ovi se podaci prikupljaju radi obrade vašeg zahtjeva za ostvarivanje prava.

Podaci označeni zvjezdicom u upitniku moraju se obavezno navesti za slanje obrasca i obradu vašeg zahtjeva.

Prikupljeni podaci bit će dostavljeni voditelju obrade vaših podataka i njihovom službeniku za zaštitu podataka radi obrade ovih zahtjeva.

Čuvaju se tijekom vremena analize i odgovora na isti.Imate pravo pristupa, ispravka i brisanja vaših osobnih podataka. Također se možete usprotiviti obradi vaših podataka.

Za ostvarivanje ovih prava ili za bilo kakva pitanja o obradi vaših podataka, morate ispuniti ovaj obrazac.

Ako smatrate, nakon što nas kontaktirate, da se vaša prava na "Zaštitu podataka" ne poštuju, možete podnijeti pritužbu nadležnom tijelu za zaštitu podataka.